Could Another US FDA Safety Alert Foreshadow Withdrawal Of Intercept’s Ocaliva?

 
• By Sue Sutter
  
Caution warning
US FDA has issued a fourth safety alert related to liver injury for Intercept's Ocaliva. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Drug Safety

More from Pathways & Standards